Glucose metabolism in mammalian cell culture: New insights for tweaking vintage pathways

Trends in Biotechnology

Volumn 28, Issue 9, 2010, Pages 476-484

  Mulukutla, Bhanu Chandra ^a   Khan, Salmaan ^b   Lange, Alex ^b   Hu, Wei Shou ^a  

^a University of Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECT; BIOPROCESSING; CELL LINES; CELLULAR ENERGY; ENERGY METABOLISM; GLUCOSE CONSUMPTION; GLUCOSE METABOLISM; MAMMALIAN CELL CULTURE; MAMMALIAN CELLS; PROCESS IMPROVEMENT; PROCESS PRODUCTIVITY; THERAPEUTIC PROTEIN;

ANIMAL CELL CULTURE; CELL PROLIFERATION; GLUCOSE; MAMMALS; METABOLISM; PRODUCTIVITY;

CELL CULTURE;

EPIDERMAL GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PROTEIN P53; SOMATOMEDIN;

ANIMAL CELL; BIOPROCESS; CELL CULTURE; CELL PROLIFERATION; ENERGY METABOLISM; ENZYME METABOLISM; GLUCOSE METABOLISM; GROWTH REGULATION; MAMMAL CELL; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW;

ANIMALS; CELL CULTURE TECHNIQUES; GLUCOSE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

MAMMALIA;

EID: 77955843732     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2010.06.005     Document Type: Review

References (60)

1. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
2. Schwer B., Verdin E. Conserved metabolic regulatory functions of sirtuins. Cell Metab. 2008, 7:104-112.
3. Nakae J., et al. The FoxO transcription factors and metabolic regulation. FEBS Lett. 2008, 582:54-67.
4. Kroemer G., Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008, 13:472-482.
5. Frame K.K., Hu W.S. Kinetic study of hybridoma cell growth in continuous culture: II. Behavior of producers and comparison to nonproducers. Biotechnol. Bioeng. 1991, 38:1020-1028.
6. Rubi B., et al. The malate-aspartate NADH shuttle member Aralar1 determines glucose metabolic fate, mitochondrial activity, and insulin secretion in beta cells. J. Biol. Chem. 2004, 279:55659-55666.
7. Costa Leite T., et al. Lactate favours the dissociation of skeletal muscle 6-phosphofructo-1-kinase tetramers down-regulating the enzyme and muscle glycolysis. Biochem. J. 2007, 408:123-130.
8. Okar D.A., et al. PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem. Sci. 2001, 26:30-35.
9. Atsumi T., et al. High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res. 2002, 62:5881-5887.
10. Manes N.P., El-Maghrabi M.R. The kinase activity of human brain 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase is regulated via inhibition by phosphoenolpyruvate. Arch. Biochem. Biophys. 2005, 438:125-136.
11. Christofk H.R., et al. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 2008, 452:181-186.
12. Christofk H.R., et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-233.
13. Barthel A., et al. Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1. J. Biol. Chem. 1999, 274:20281-20286.
14. Rathmell J.C., et al. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol. Cell Biol. 2003, 23:7315-7328.
15. Deprez J., et al. Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J. Biol. Chem. 1997, 272:17269-17275.
16. Berwick D.C., et al. The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes. J. Biol. Chem. 2002, 277:33895-33900.
17. Porstmann T., et al. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 2005, 24:6465-6481.
18. Porstmann T., et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 2008, 8:224-236.
19. del Peso L., et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997, 278:687-689.
20. Dijkers P.F., et al. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J. Cell Biol. 2002, 156:531-542.
21. Majewski N., et al. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol. Cell 2004, 16:819-830.
22. Gottlob K., et al. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 2001, 15:1406-1418.
23. Wullschleger S., et al. TOR signaling in growth and metabolism. Cell 2006, 124:471-484.
24. Zhou B.P., et al. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 2001, 3:245-252.
25. Liang J., et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 2002, 8:1153-1160.
26. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
27. Carling D. The AMP-activated protein kinase cascade--a unifying system for energy control. Trends Biochem. Sci. 2004, 29:18-24.
28. Marsin A.S., et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr. Biol. 2000, 10:1247-1255.
29. Marsin A.S., et al. The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J. Biol. Chem. 2002, 277:30778-30783.
30. Barnes K., et al. Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J. Cell Sci. 2002, 115:2433-2442.
31. Kurth-Kraczek E.J., et al. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 1999, 48:166-1671.
32. Zong H., et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:15983-15987.
33. Canto C., et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009, 458:1056-1060.
34. Inoki K., et al. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003, 115:577-590.
35. Clarke P.R., Hardie D.G. Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver. EMBO J. 1990, 9:2439-2446.
36. Hardie D.G., Pan D.A. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem. Soc. Trans. 2002, 30:1064-1070.
37. Zhou G., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 2001, 108:1167-1174.
38. Koo S.H., et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 2005, 437:1109-1111.
39. Osthus R.C., et al. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J. Biol. Chem. 2000, 275:21797-21800.
40. Shim H., et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:6658-6663.
41. Kim J.W., et al. Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Mol. Cell. Biol. 2004, 24:5923-5936.
42. Gao, P. et al. (2009) c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature.
43. Wise D.R., et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:18782-18787.
44. Vousden, K.H., and Ryan, K.M. (2009) p53 and metabolism. Nat. Rev. 9, 691-700.
45. Schwartzenberg-Bar-Yoseph F., et al. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004, 64:2627-2633.
46. Kondoh H., et al. Glycolytic enzymes can modulate cellular life span. Cancer Res. 2005, 65:177-185.
47. Matoba S., et al. p53 regulates mitochondrial respiration. Science 2006, 312:1650-1653.
48. Bensaad K., et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126:107-120.
49. Vander Haar E., et al. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat. Cell Biol. 2007, 9:316-323.
50. Gwinn D.M., et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 2008, 30:214-226.
51. Jones R.G., et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 2005, 18:283-293.
52. Budanov A.V., Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 2008, 134:451-460.
53. Stambolic V., et al. Regulation of PTEN transcription by p53. Mol. Cell 2001, 8:317-325.
54. Gottlieb T.M., et al. Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene 2002, 21:1299-1303.
55. Seth G., et al. Engineering cells for cell culture bioprocessing--physiological fundamentals. Adv. Biochem. Eng. Biotechnol. 2006, 101:119-164.
56. Fan Y., et al. Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition. J. Biol. Chem. 2010, 285:7324-7333.
57. Vlahos C.J., et al. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 1994, 269:5241-5248.
58. Jimenez R.H., et al. Rapamycin response in tumorigenic and non-tumorigenic hepatic cell lines. PloS one 2009, 4:e7373.
59. Fukuchi K., et al. Phosphatidylinositol 3-kinase inhibitors, Wortmannin or LY294002, inhibited accumulation of p21 protein after gamma-irradiation by stabilization of the protein. Biochim. Biophys. Acta. 2000, 1496:207-220.
60. Clem B., et al. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol. Cancer Ther. 2008, 7:110-120.